0001214659-20-003820.txt : 20200428
0001214659-20-003820.hdr.sgml : 20200428
20200428163328
ACCESSION NUMBER: 0001214659-20-003820
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200424
FILED AS OF DATE: 20200428
DATE AS OF CHANGE: 20200428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kazam Joshua A
CENTRAL INDEX KEY: 0001221355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 20825589
MAIL ADDRESS:
STREET 1: 689 5TH AVENUE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER NAME:
FORMER CONFORMED NAME: KAZAM JOSHUA A
DATE OF NAME CHANGE: 20070920
FORMER NAME:
FORMER CONFORMED NAME: KAZAM JOSHOA A
DATE OF NAME CHANGE: 20030303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-48642.xml
PRIMARY DOCUMENT
X0306
4
2020-04-24
0001737287
Allogene Therapeutics, Inc.
ALLO
0001221355
Kazam Joshua A
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Common Stock
2020-04-24
4
J
false
8039
0.00
A
1023336
D
Pro rata distribution of shares of the Issuer's common stock from VVAG LLC to its members.
/s/ Veer Bhavnagri, Attorney-in-Fact
2020-04-28